Effectiveness and safety of romiplostim among patients with newly diagnosed, persistent and chronic ITP in routine clinical practice in central and Eastern Europe: an analysis of the PLATON study

The objective of this analysis was to assess the effectiveness and safety of romiplostim in the real-world by duration of primary immune thrombocytopenia (ITP): 12 ('chronic') months. This was a post-hoc analysis of the PLATON single-arm, observational cohort study of adults from five Cent...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Hematology (Luxembourg) 2021-01, Vol.26 (1), p.497-502
Hauptverfasser:	Skopec, Barbara, Sninska, Zuzana, Tzvetkov, Nikolai, Ivanushkin, Vladlen, Björklöf, Katja, Hippenmeyer, Jane, Mihaylov, Georgi
Format:	Artikel
Sprache:	eng
Schlagworte:	bleeding bleeding disorder Blood Platelets - drug effects Central and Eastern Europe Europe - epidemiology Europe, Eastern - epidemiology Humans Immune thrombocytopenia (ITP) Purpura, Thrombocytopenic, Idiopathic - diagnosis Purpura, Thrombocytopenic, Idiopathic - drug therapy Purpura, Thrombocytopenic, Idiopathic - epidemiology real-world evidence Receptors, Fc - therapeutic use Receptors, Thrombopoietin - agonists Recombinant Fusion Proteins - adverse effects Recombinant Fusion Proteins - therapeutic use romiplostim thrombocytopenia Thrombopoietin - adverse effects Thrombopoietin - therapeutic use thrombopoietin receptor agonist TPO Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!